Korean J Clin Microbiol.  2006 Apr;9(1):51-57.

A Decrease in Erythromycin Resistance Rate of Streptococcus pyogenes in 2004 in Jinju

• Koh EH
• Maeng KY
• Kim S
• Jeong HJ
• Lee NY

Abstract

BACKGROUND: The erythromycin (EM) resistance rates and emm genotypes of Streptococcus pyogenes could vary by geographical location and study period. The purpose of this study, involving a large number of children, was to determine EM resistance rate and its resistance mechanism of S. pyogenes, and to compare these results with those of previous studies performed at the same area.
METHODS
Throat cultures were taken from 2,351 healthy children of four elementary schools from October through December, 2004 in Jinju. A total of 328 strains of S. pyogenes were isolated. Antimicrobial susceptibility test was performed by the agar dilution method against six antimicrobial agents. The phenotypes of EM resistance were evaluated by the double-disk diffusion test and the frequency of ermB and mefA genes was determined by polymerase chain reaction.
RESULTS
Resistance rates of S. pyogenes to EM, clindamycin and tetracycline were 9.8%, 8.8% and 18.3%, respectively. Almost all isolates were susceptible to ofloxacin, levofloxacin and chloramphenicol. Constitutive resistance (CR) was observed in 87.5%, M phenotype in 9.4%, and inducible resistance only in 3.1%. The ermB and mefA genes were present in 90.6% and 9.4% of the isolates, respectively.
CONCLUSION
The resistance rate to EM of S. pyogenes was 9.8% in 2004, which was a large drop from the 51% shown in 2002. CR with the ermB gene was predominant, suggesting that most of the EM resistant isolates have a high level of resistance.

Keyword

Streptococcus pyogenes; Erythromycin resistance; ermB; mefA

MeSH Terms

Agar
Anti-Infective Agents
Child
Chloramphenicol
Clindamycin
Diffusion
Erythromycin*
Genotype
Gyeongsangnam-do*
Humans
Levofloxacin
Ofloxacin
Pharynx
Phenotype
Polymerase Chain Reaction
Streptococcus pyogenes*
Streptococcus*
Tetracycline
Agar
Anti-Infective Agents
Chloramphenicol
Clindamycin
Erythromycin
Ofloxacin
Tetracycline